Medical Xpress
Hiding who you are can take a toll on mental health
Concealing a core aspect of your identity — even momentarily — carries a measurable psychological cost, according to new research from the University of Michigan. The study highlights how seemingly routine decisions about self-disclosure accumulate into significant effects on emotional well-being. For marginalized individuals who routinely mask their identities, the findings underscore a hidden burden with real mental health implications.
Read article →Guardian Health
Lupus patients in England in remission after pioneering NHS trial of GM therapy
Five lupus patients in England have achieved remission following CAR T-cell therapy, a treatment that genetically engineers a patient's own white blood cells to target the disease. The pioneering NHS trial marks a significant step forward in treating lupus, a chronic autoimmune condition that affects thousands and currently has no cure. If results hold, the approach could represent a fundamental shift in how autoimmune diseases are managed long-term.
Read article →Medical Xpress
A higher-dose flu shot could spare millions of older adults a hospital stay
A new study in JAMA Network Open found that a high-dose flu vaccine — containing four times the antigen of a standard shot — significantly reduces hospitalization and death risk in adults over 65. The findings carry real weight given that older adults represent a disproportionate share of severe influenza cases each season. Wider adoption of the higher-dose formulation could translate to millions of prevented hospital stays annually.
Read article →Guardian Health
‘Autistic kids are being experimented on’: inside America’s booming market for unproven stem cell infusions
Desperate families of autistic children are spending tens of thousands of dollars on unproven stem cell infusions, drawn to clinics offering treatments that lack FDA approval or clinical evidence. The trend is accelerating amid signals of support from the current US health secretary, lending a veneer of legitimacy to a largely unregulated market. Critics warn that vulnerable children are effectively serving as paying test subjects in a medical Wild West.
Read article →Medical Xpress
Low dose atropine eye drops safe and effective for short-sightedness in children, clinical trial suggests
Low-dose atropine eye drops have shown promise as a safe treatment for childhood myopia, according to a clinical trial published in The BMJ. The study found measurable reductions in short-sightedness progression among UK children, though researchers note the effects are modest. The findings add to growing evidence supporting atropine as a viable clinical option for managing one of the world's most common vision conditions in young patients.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →